Filing Details

Accession Number:
0001214659-20-005427
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-05 16:05:17
Reporting Period:
2020-06-04
Accepted Time:
2020-06-05 16:05:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406834 J Keith Kendall C/O Aquestive Therapeutics, Inc.
30 Technology Drive
Warren NJ 07059
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-04 50,000 $5.11 638,964 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 18, 2020 in order to satisfy the tax obligations of the reporting person resulting from the (i) conversion of the reporting person's then existing performance-based equity interests in the Company to shares of common stock of the Company in connection with the Company's Initial Public Offering in 2018, and (ii) vesting of shares of restricted stock issued to the reporting person by the Company pursuant to the reporting person's employment agreement with the Company.